UAE Orders Recall Of Hospira's Paclitaxel Cancer Chemo Drug
This article was originally published in PharmAsia News
Abu Dhabi's Health Authority, acting in response to a U.S. FDA recall, ordered a UAE-wide recall of paclitaxel because of glass particles found in at least one batch of the injectable drug used in ovarian- and breast-cancer chemotherapy.
You may also be interested in...
Corindus Vascular Robotics Inc. expects its CorPath GRX robotic intervention system will eventually be part of a widespread system of "telerobotic" intervention sites operated by specialists located far away. See what Tejas Patel, an interventional cardiologist at the Apex Heart Institute in Ahmedabad, India, said about it here.
Japanese company starts pivotal trial with novel molecule as it looks to build oncology presence.